Expanded PBS listings for lung cancer and a chronic skin disease

24 June 2024 - Australians with non-small cell lung cancer and the chronic skin disease hidradenitis suppurativa, now have access to ...

Read more →

PHARMAC improves access to breast cancer treatments

18 June 2024 - PHARMAC has changed the criteria for two breast cancer medicines which means people with a particular ...

Read more →

New Zealand Pharmaceutical Schedule - 1 June 2024

1 June 2024 - The June 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 June 2024

1 June 2024 - The June 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Australians benefit from new life changing medicines added to the PBS

13 May 2024 - Women with endometrial cancer and people with itching associated with chronic kidney disease will benefit from ...

Read more →

Vyndamax (tafamidis) PBS listed for adult patients with wild type or hereditary transthyretin amyloid cardiomyopathy with New York Heart Association class I-II heart failure

4 May 2024 - The availability of Vyndamax on the PBS provides subsidised access to a once daily oral single ...

Read more →

Enhertu to get insurance coverage for metastatic breast/stomach cancer from April

29 March 2024 - Starting next month, health insurance benefits will be applied to treating metastatic breast and gastric cancers ...

Read more →

New Zealand Pharmaceutical Schedule - 1 May 2024

1 May 2024 - The May 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 May 2024

1 May 2024 - The May 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Australians benefit from cheaper medicines on the PBS

8 April 2024 - Australians with high cholesterol, chronic kidney disease and ovarian cancer now have access to cheaper medicines under ...

Read more →

BMS’ oral plaque psoriasis drug Sotyktu gets reimbursement starting April

1 April 2024 - Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate to severe plaque psoriasis in adults, ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2024

1 April 2024 - The April 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 April 2024

1 April 2024 - The April 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

PHARMAC funds new treatments for breast and blood cancer

27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...

Read more →

Schedule of Pharmaceutical Benefits - 1 March 2024

1 March 2024 - The March 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →